tiprankstipranks
Aquestive Therapeutics appoints Jenkins to board of directors
PremiumThe FlyAquestive Therapeutics appoints Jenkins to board of directors
24d ago
Aquestive Therapeutics initiated with an Outperform at Raymond James
PremiumThe Fly
Aquestive Therapeutics initiated with an Outperform at Raymond James
29d ago
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
PremiumPress Releases
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
1M ago
Aquestive Therapeutics price target raised to $9 from $7 at H.C. Wainwright
PremiumThe FlyAquestive Therapeutics price target raised to $9 from $7 at H.C. Wainwright
1M ago
Aquestive Therapeutics price target raised to $10 from $8 at JMP Securities
PremiumThe Fly
Aquestive Therapeutics price target raised to $10 from $8 at JMP Securities
1M ago
Aquestive Therapeutics’ Anaphylm meets endpoints in Phase 3 allergy study
PremiumThe Fly
Aquestive Therapeutics’ Anaphylm meets endpoints in Phase 3 allergy study
1M ago
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
PremiumPress ReleasesAquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
2M ago
Aquestive Therapeutics options imply 25.7% move in share price post-earnings
PremiumThe Fly
Aquestive Therapeutics options imply 25.7% move in share price post-earnings
2M ago
Options Volatility and Implied Earnings Moves Today, March 05, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 05, 2024
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100